Finance: Page 53

Cresco Labs Launches New Value Brand, High Supply, for Cannabis Consumers on a Budget

The product portfolio includes vape pens, popcorn, shake and pre-rolls.

How Willie’s Reserve Partnered with Fellow Artists to Launch in Maryland’s Medical Cannabis Market: The Starting Line

VP of Brands Elizabeth Hogan shares how the brand expanded its Margo Price and Nathaniel Rateliff product lines to Maryland in partnership with Culta, a vertically integrated cannabis operator in the state.

Washington, D.C. Mayor Temporarily Allows Medical Cannabis Dispensaries to Provide Delivery and Curbside Pickup Services

Mayor Muriel Bowser announced an emergency rule that will remain in effect for 120 days or until 45 days after the public health emergency ends, whichever comes first.

How Cannabis Businesses Can Respond to Coronavirus-Related Legal Claims

Consumers, shareholders and employees could all bring forth claims due to the pandemic and its economic fallout.

The Green Organic Dutchman Signs Letter of Intent with Quebec's SQDC

The company now has agreements in place with every province except PEI.

Latest Tax Administration Report Raises Questions for Cannabis Businesses

Are more tax audits coming? And does a new section of the IRS Tax Code offer relief from 280E?

Green Thumb Industries (GTI) Announces Resignation of Armen Yemenidjian

Yemenidjian has stepped down from his role as president in order to spend more time with his family in Nevada.

Planet 13 Announces Termination of Santa Ana Acquisition

The acquisition was terminated due to unmet conditions in the definitive agreement.

Aurora Cannabis Provides Update on Initiatives to Strengthen Liquidity, Business Transformation Plan and COVID-19 Operational Response

The company has strengthened its cash position with plans for additional flexibility given the current economic uncertainty.

DEA Deschedules Epidiolex, Senators Urge SBA to Extend Economic Assistance to Cannabis Businesses: Week in Review

Effective immediately, the DEA has descheduled GW Pharmaceuticals’ Epidiolex, which was initially listed under Schedule V following its approval in 2018.

Rubicon Organics Announces Sale of Washington Greenhouse, Strengthening of Balance Sheet and Strategic Exit from the U.S.

Proceeds from the sale of the greenhouse will strengthen the company’s balance sheet, providing working capital to ramp-up production and sales across Canada.

Federal Stay-at-Home Order? What Cannabis Businesses Need to Know

Industry advocates and attorneys weigh in on what federal COVID-19 guidance might entail and how it could impact businesses in the space.

Previous Page

Page 53 of 184

Next Page